neomycin



neomycin


SMILES NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O
InChIKey PGBHMTALBVVCIT-VCIWKGPPSA-N

Chemical Properties

Hydrogen bond acceptors 19
Hydrogen bond donors 13
Rotatable bonds 9
Molecular weight (Da) 614.3


No bioactivity data available.

neomycin


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.